Health Technology Company
Sign up today and learn more about Counsyl Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Counsyl Stock
Counsyl is a genetic screening and counseling services company. The company provides women and their families with actionable information to guide health decisions. Counsyl operates a clinical laboratory that offers the Foresight™ Carrier Screen, Prelude™ Prenatal Screen and Reliant™ Cancer Screen, and supporting services through Counsyl Complete™, a proprietary suite of solutions, each designed to integrate into clinic workflows and patients’ lives. Their genetic screens provide actionable information to patients and their healthcare providers through process that facilitates clinical decision-making.
The company launched their first commercial screen in 2009, and in January 2018, reached a milestone of having delivered one million patient results.
How Counsyl Works
Wish, Scopely, Opendoor, Dollar Shave Club, Gusto, Coalition, Zipline, Plaid, Crusoe Energy Systems, Guild Education
Lyft, SpaceX, Spotify, Airbnb, Stripe, Anduril Industries, Flexport, Palantir Technologies, Wish, Compass
WeWork, Alibaba, Spotify, Compass, Pinterest, Bloom Energy, Oscar Health, Circle, Automation Anywhere, Zymergen
Great Oaks Venture Capital
Acorns, Bolt Financial, Workrise, Collective Health, Course Hero, SingleStore, Virta Health, Human Interest, Maven Clinic, Petal
Co-Founder & Chief Executive Officer
Co-Founder & Chief Science Officer
Chief Medical Officer
James Goldberg, PhD
Chief Financial Officer
Chief Commercial Officer
Co-Founder & SVP, Technology
hcanews.com - Feb, 2 2018Counsyl's 1M Genetic Screens Underscore Popularity of Testing
Business Wire (press release) - Jan, 30 2018Counsyl Surpasses One Million Genetic Screens
Business Wire (press release) - Jan, 16 2018Counsyl Secures Approval From New York State Department of ...
Business Wire (press release) - Jan, 4 2018Counsyl Appoints Ann Rhoads to Board of Directors | Business Wire
Business Wire (press release) - Dec, 14 2017Counsyl Appoints Pamela Sedmak to Board of Directors
Business Wire (press release) - Dec, 4 2017Counsyl Appoints Noah Nasser as Chief Commercial Officer
GenomeWeb - Nov, 6 2017Counsyl Raises $80M
Business Wire (press release) - Sep, 11 2017Counsyl Experts to Speak and Present Research at National Society of Genetic Counselors (NSGC) Annual Conference
News-Medical.net - Jul, 25 2017Counsyl unveils significant enhancements to expanded carrier screening panel
Business Wire (press release) - Jul, 19 2017Counsyl Announces Industry Leading Enhancements to Expanded Carrier Screening Panel
Business Wire (press release) - Jul, 10 2017Counsyl and Angsana Bring Expanded Carrier Screening to Clinicians and Patients in Hong Kong
Business Wire (press release) - May, 3 2017Explore the Latest in Carrier Screening with Counsyl at the 2017 ACOG Annual Clinical and Scientific Meeting
Business Wire (press release) - Apr, 26 2017SYNLAB and Counsyl Enter Into Agreement to Offer Genetic Screening for Serious Inherited Health Conditions in ...
GenomeWeb - Mar, 29 2017Perthera Partners With Counsyl to Offer Germline Testing of Cancer Patients
- Mar, 22 2017Counsyl to Host Evolution of Carrier Screening Symposium, Present Nine Research Posters at the 2017 ACMG Annual Clinical Genetics Meeting
Business Wire (press release) - Jan, 6 2017Counsyl Strengthens Focus on Preventive Genetic Testing for Women's Health
The MIT Technology Review - Mar, 16 2015A Contrarian in Biotech
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase